These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


961 related items for PubMed ID: 16202788

  • 21. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U, Moatter T.
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [Abstract] [Full Text] [Related]

  • 22. Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
    Doull I, Course CW, Hanks RE, Southern KW, Forton JT, Thia LP, Moat SJ.
    Arch Dis Child; 2021 Mar; 106(3):253-257. PubMed ID: 32859613
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Rock MJ, Mischler EH, Farrell PM, Wei LJ, Bruns WT, Hassemer DJ, Laessig RH.
    Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Mucoviscidosis screening of newborn infants in the Dresden district. Results from 1 June 1996 to 31 March 2000].
    Wunderlich P, Stopsack M, Paul KD, Rösen-Wolff A.
    Dtsch Med Wochenschr; 2000 Nov 10; 125(45):1356-60. PubMed ID: 11109423
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].
    Barthellemy S, Maurin N, Roussey M, Férec C, Murolo S, Berthézène P, Iovanna JL, Dagorn JC, Sarles J.
    Arch Pediatr; 2001 Mar 10; 8(3):275-81. PubMed ID: 11270251
    [Abstract] [Full Text] [Related]

  • 30. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH.
    N Engl J Med; 1997 Oct 02; 337(14):963-9. PubMed ID: 9395429
    [Abstract] [Full Text] [Related]

  • 31. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L, Ferraguti G, Stamato A, Narzi F, Valentini SB, Lelli A, Delaroche I, Lucarelli M, Strom R, Quattrucci S.
    Clin Genet; 2007 Jul 02; 72(1):39-46. PubMed ID: 17594398
    [Abstract] [Full Text] [Related]

  • 32. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL.
    J Pediatr; 2005 Sep 02; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
    Kloosterboer M, Hoffman G, Rock M, Gershan W, Laxova A, Li Z, Farrell PM.
    Pediatrics; 2009 Feb 02; 123(2):e338-46. PubMed ID: 19171585
    [Abstract] [Full Text] [Related]

  • 35. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
    Munck A, Roussey M.
    Arch Pediatr; 2008 Jun 02; 15 Suppl 1():S1-6. PubMed ID: 18822253
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J, Clements B, Australian Paediatric Respiratory Group.
    Pediatr Pulmonol; 2005 May 02; 39(5):440-6. PubMed ID: 15704202
    [Abstract] [Full Text] [Related]

  • 40. Thirty-years of screening for cystic fibrosis in East Anglia.
    Calvin J, Hogg SL, McShane D, McAuley SA, Iles R, Ross-Russell R, MacLean FM, Heeley ME, Heeley AF, Norfolk, Suffolk and Cambridgeshire Paediatric Cystic Fibrosis Network.
    Arch Dis Child; 2012 Dec 02; 97(12):1043-7. PubMed ID: 23076339
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 49.